Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia,
bipolar disorders and other psychotic disorders. However, they might cause metabolic …

Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

People with elevated, non-diabetic, levels of blood glucose are at risk of progressing to
clinical type 2 diabetes and are commonly termed 'prediabetic'. The term prediabetes …

Objective: A combination of olanzapine and the opioid receptor antagonist samidorphan is
under development for the treatment of schizophrenia and bipolar I disorder. The single …

Background Most antipsychotics are associated with weight gain and other metabolic
complications. Several randomized trials have shown metformin to be effective, but this still …

Second generation antipsychotics (SGAs), such as clozapine, olanzapine, risperidone and
quetiapine, are among the most effective therapies to stabilize symptoms schizophrenia (SZ) …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Context Weight gain, a common adverse effect of antipsychotic medications, is associated
with medical comorbidities in psychiatric patients. Objective To test the efficacy of lifestyle …